ZULRESSO may help
Postpartum depression (PPD) can take you away from special moments with your baby. Learn more about treatment for PPD with ZULRESSO® (brexanolone).
Please confirm that you are a US healthcare provider.
This link will take you to another Sage Therapeutics, Inc. website.
Sage Therapeutics, Inc. makes no representation as to the information contained on sites we do not own or control. Sage Therapeutics, Inc. does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Not actual patients.
Postpartum depression (PPD) can take you away from special moments with your baby. Learn more about treatment for PPD with ZULRESSO® (brexanolone).
ZULRESSO® (brexanolone) is the first FDA-approved treatment for postpartum depression in individuals 15 and older.
In clinical studies, moms treated with ZULRESSO experienced a greater reduction of depressive symptoms vs placebo in 2.5 days (60 hours).* Symptoms were measured at the beginning of treatment using a standard depression scale and again at the end of treatment.
In these studies, moms who took ZULRESSO generally still felt better 30 days after treatment began, as measured by a standard depression scale.* This 30-day measurement was also a preplanned part of the study.
*Individual results may vary.
See what moms had to say about their experience with ZULRESSO treatment. Your experience may differ.
Looking for more information about ZULRESSO and treatment? Download the Patient Brochure or share it.
ZULRESSO® is a prescription medicine used to treat Postpartum Depression in individuals 15 years and older.
It is not known if ZULRESSO is safe and effective in individuals less than 15 years of age.
ZULRESSO can cause serious side effects, including:
Before receiving ZULRESSO, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
ZULRESSO and some medicines may interact with each other and cause serious side effects.
Especially tell your healthcare provider if you take other antidepressants, opioids, or Central Nervous System (CNS) depressants (such as benzodiazepines).
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine. Your healthcare provider will decide if other medicines can be taken with ZULRESSO.
ZULRESSO is given to you by continuous intravenous (IV) infusion into your vein. The infusion will last for a total of 60 hours (2.5 days).
ZULRESSO can cause serious side effects, including:
How can I watch for and try to prevent suicidal thoughts and actions?
Tell your healthcare provider right away if you have any of the following symptoms, especially if they are new, worse, or worry you:
The most common side effects of ZULRESSO include:
These are not all the side effects of ZULRESSO.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please also see Full Prescribing Information including Boxed Warning and Medication Guide for ZULRESSO® and discuss any questions you may have with your healthcare provider.
ZULRESSO® (brexanolone) is a prescription medicine used to treat Postpartum Depression in individuals 15 years and older.
IMPORTANT SAFETY INFORMATION
ZULRESSO can cause serious side effects, including: Excessive sedation and sudden loss of consciousness. ZULRESSO may cause you to feel very sleepy (excessive sedation) or pass out (loss of consciousness). Your healthcare provider should check you for symptoms of excessive sleepiness every 2 hours while you are awake